AzTrials
AzTrials

Benign Laryngeal LesionLASERNCT06912945

Factors Affecting Outcomes of Using Diode Laser Both 980 nm Wave Length and 450 Wavelength on Benign Laryngeal Lesions in Comparison to Traditional Cold Instrumentations as Regard Parameters of Laser Device, Nature of Lesion and Patient Factors

A study testing using diode laser 980nm wavelength in benign laryngeal lesions, using diode laser 450nm wavelength in benign laryngeal lesions and using traditional cold instrumentations in benign laryngeal lesions in people with Benign Laryngeal Lesion, run by Sohag University at 1 site in Egypt.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

Studying the different Factors affecting the outcomes of using diode laser both 980 nm wave length and 450 wavelength on benign laryngeal lesions in comparison to traditional cold instrumentations Read more about this study

Who is it for?
Any age
Conditions the study is for
Benign Laryngeal Lesion
What is being tested?
using diode laser 980nm wavelength in benign laryngeal lesions, using diode laser 450nm wavelength in benign laryngeal lesions and using traditional cold instrumentations in benign laryngeal lesions
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
108 participants
Where
1 siteEgypt
Study dates
1 Oct 2024to 28 Feb 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • All patients with benign laryngeal lesions

Who cannot join

  • patients presenting with or have history of malignant laryngeal lesion

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Egypt1 site
  • Sohag University

    Sohag, Sohag Governorate, 82511

Other trials in Egypt

About this study

Official title: Factors Affecting the Outcomes of Using the Diode Laser in Benign Laryngeal Lesions

Studying the different Factors affecting the outcomes of using diode laser both 980 nm wave length and 450 wavelength on benign laryngeal lesions in comparison to traditional cold instrumentations

Being tested
using diode laser 980nm wavelength in benign laryngeal lesions, using diode laser 450nm wavelength in benign laryngeal lesions, using traditional cold instrumentations in benign laryngeal lesions
Keywords
diode, benign, laryngeal, laser
Medical subject headings
Laryngeal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • using diode laser 980nm wavelength in benign laryngeal lesionsProcedure or surgery

    using diode laser 980nm wavelength in treatment of benign laryngeal lesions

  • using diode laser 450nm wavelength in benign laryngeal lesionsProcedure or surgery

    using diode laser 450nm wavelength in treatment of benign laryngeal lesions

  • using traditional cold instrumentations in benign laryngeal lesionsProcedure or surgery

    using traditional cold instrumentations in treatment of benign laryngeal lesions

Study groups in NCT06912945
Study groupRoleWhat they receive
Group (A)Active comparatorusing diode laser 980nm wavelength in benign laryngeal lesions
Receives: Procedure: using diode laser 980nm wavelength in benign laryngeal lesions
Group (B)Active comparatorusing diode laser 450nm wavelength in benign laryngeal lesions
Receives: Procedure: using diode laser 450nm wavelength in benign laryngeal lesions
Group (C)Active comparatorusing traditional cold instrumentations in benign laryngeal lesions
Receives: Procedure: using traditional cold instrumentations in benign laryngeal lesions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in voice handicap index Arabic version (VHI-Arabic)

    change in Voice handicap index Arabic version from baseline before treatment and after treatment

    Measured: 2 months after treatment

  2. change in voice acoustic analysis

    change in voice acoustic analysis including change in jitter and shimmer values from baseline preoperative and 2 months after treatment

    Measured: 2 months after treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Apr 2025
  2. Study start1 Oct 2024
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion28 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
108 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06912945
Sponsor's protocol ID
Soh-Med-24-12-3MD
Acronym
LASER
Status last verified
Aug 2025
First submitted
25 Mar 2025
Last updated
24 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Arroyo HH, Neri L, Fussuma CY, Imamura R. Diode Laser for Laryngeal Surgery: a Systematic Review. Int Arch Otorhinolaryngol. 2016 Apr;20(2):172-9. doi: 10.1055/s-0036-1579741. Epub 2016 Mar 4.

    PubMed 27096024

Questions about this trial

What is this clinical trial studying?

A study testing using diode laser 980nm wavelength in benign laryngeal lesions, using diode laser 450nm wavelength in benign laryngeal lesions and using traditional cold instrumentations in benign laryngeal lesions in people with Benign Laryngeal Lesion, run by Sohag University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 24 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in voice handicap index Arabic version (VHI-Arabic) (time frame: 2 months after treatment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06912945, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Aug 2025; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in